Zdrowie i gospodarka · 23/05/2017
FDA Requests Public Comment on Proposed Collection of Information for Prescription Drug Advertisements
The Food and Drug Administration is seeking public input on proposed changes to its regulations regarding the disclosure of third-party information in prescription drug advertisements, as mandated by the Paperwork Reduction Act of 1995.